Paracetamol, ethanol, and salicylate assays offer laboratories the ability to test for disorders associated with poisoning, toxicity, and overdose and assist in rapid diagnosis and treatment
Bayer Diagnostics has released three new toxicology assays - paracetamol, ethanol, and salicylate - on its Advia 1650 and 2400 clinical chemistry systems.
With immediate availability, Bayer offers laboratories the ability to test for disorders associated with poisoning, toxicity, and overdose and assist in the rapid diagnosis and treatment associated with these emergency medical conditions.
The Advia 1650 and 2400 clinical chemistry systems provide high speed, automation-compatible testing platforms with a comprehensive menu of almost 70 assays including general and special chemistry, specific protein and therapeutic drug monitoring.
With open channels for user-defined applications, Advia chemistry systems are said to offer unparalleled, cost-effective workstation consolidation.
Bayer says the availability of these new chemistry methods demonstrates its continued commitment towards menu development on for the Advia systems.
